This project has been flagged by a community member as inappropriate due to reason below.*
Slingshot & STAT have partnered to provide you with interviews with experts led by STAT's reporters. This call is on:

Key Takeaways from ASCO 2019 - Digesting the new data with a Key Opinion Leader


Who's the expert?

Name: Dr Foluso Ademuyiwa - MD

Institution: WUSTL

  • Medical oncologist at Washington University in St. Louis whose research focuses on developing novel treatments for patients with triple negative breast cancer (TNBC). 
  • Treats ~150 patients with HER2-positive breast cancer (total) & 15 patients with triple negative breast cancer per week.
  • Principal Investigator on an NIH-funded clinical trial investigating a unique chemotherapy combination in the pre-operative setting in patients with TNBC.

Interview Goal
To get on the ground insights from ASCO 2019 with a focus on what companies and data sets were most surprising and exciting. 

Are You Interested In These Questions?

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.


*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.